Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0115
0.00 (0.00%)
Feb 13, 2026, 9:30 AM EST

YBGJ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-1.11-1.78-1.2-1.2-1.54-0.71
Depreciation & Amortization
0.180.180.190.030.020.01
Asset Writedown & Restructuring Costs
----0.01-
Other Operating Activities
-0.150.01----
Change in Accounts Receivable
0.1-0.09-0.030.11-0.16-0
Change in Inventory
0.190.180.11-0.16-0.1-0.07
Change in Accounts Payable
0.050.210.280.270.170.1
Change in Other Net Operating Assets
-0.9-0.06-0.090.350.570.77
Operating Cash Flow
-1.65-1.34-0.74-0.6-1.020.1
Capital Expenditures
-----0.56-0.04
Sale of Property, Plant & Equipment
0.080.12----
Sale (Purchase) of Intangibles
----0.04--0.05
Investing Cash Flow
0.080.12--0.04-0.56-0.1
Short-Term Debt Issued
-1.030.750.67--
Total Debt Issued
1.511.030.750.67--
Net Debt Issued (Repaid)
1.511.030.750.67--
Issuance of Common Stock
----0.131.38
Other Financing Activities
0.080.37----
Financing Cash Flow
1.581.410.750.670.131.38
Foreign Exchange Rate Adjustments
-0.01-0.19-0.02-0.040.1-0.01
Net Cash Flow
00-0.01-0.01-1.361.38
Free Cash Flow
-1.65-1.34-0.74-0.6-1.590.06
Free Cash Flow Margin
--38551.27%-122.21%-576.27%-127.42%4.32%
Free Cash Flow Per Share
-0.01-0.01-0.06-0.01-0.010.00
Levered Free Cash Flow
-3.250.010.45-0.37-0.950.27
Unlevered Free Cash Flow
-3.250.010.45-0.37-0.950.27
Change in Working Capital
-0.560.250.270.580.490.8
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.